by GlobeNewsWire | Sep 9, 2015 | Globe Newswire
NEWARK, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) — Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, today announced it has commenced dosing...
by GlobeNewsWire | Sep 9, 2015 | Globe Newswire
–Peregrine and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial– –Phase III SUNRISE Clinical Trial on Track to Complete Patient Enrollment by Calendar Year-End 2015– –Avid Bioservices Reports $9.4 Million in First...
by GlobeNewsWire | Sep 9, 2015 | Globe Newswire
Q4 Revenue and non-GAAP operating loss better than guidance ranges FY 15 Gross Product Billings of $63.4 million, a 44% year-over-year increase FY 15 Gross Profit of $43.6 million, a 75% year-over-year increase SAN JOSE, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) —...
by GlobeNewsWire | Sep 9, 2015 | Globe Newswire
CHARLESTON, S.C., Sept. 9, 2015 (GLOBE NEWSWIRE) — Benefitfocus, Inc. (NASDAQ:BNFT), a leading provider of cloud-based benefits software solutions, today announced that its Chief Financial Officer, Milt Alpern, will present at the Deutsche Bank Technology...
by GlobeNewsWire | Sep 9, 2015 | Globe Newswire
TORRANCE, Calif., Sept. 09, 2015 (GLOBE NEWSWIRE) — Farmer Bros. Co. (NASDAQ:FARM) today reported financial results for the fourth quarter and fiscal year ended June 30, 2015. Fourth Quarter Fiscal 2015 Highlights: Net sales increased 1.8% to $132.6 million in...